Literature DB >> 16311016

Mouse cDNA microarray analysis uncovers Slug targets in mouse embryonic fibroblasts.

Camino Bermejo-Rodríguez1, María Pérez-Caro, Pedro Antonio Pérez-Mancera, Margarita Sánchez-Beato, Miguel A Piris, Isidro Sánchez-García.   

Abstract

There is a need to reveal mechanisms that account for maintenance of the mesenchymal phenotype in normal development and cancer. Slug (approved gene symbol Snai2), a member of the Snail gene family of zinc-finger transcription factors, is believed to function in the maintenance of the nonepithelial phenotype. This study identified candidate Slug target genes linked to Slug gene suppression in primary mouse embryonic fibroblasts. Expression analyses were performed with a mouse cDNA microarray (Mousechip-CNIO) containing 15,000 clones. A total of 15 novel Slug target species were validated by real-time PCR or Western analyses. These included self-renewal genes (Bmi1, Nanog, Gfi1), epithelial-mesenchymal genes (Tcfe2a, Ctnb1, Sin3a, Hdac1, Hdac2, Muc1, Cldn11), survival genes (Bcl2, Bbc3), and cell cycle/damage genes (Cdkn1a, Rbl1, Mdm2). Expression patterns were studied in wild-type MEFs and Slug-deficient MEFs. Slug-complementation studies recovered aberrant gene expression in cells lacking Slug, indicating that these genes were regulated directly by Slug. These results highlight their potential roles in mediating Slug function in mesenchymal cells and may help to identify novel therapeutic biomarkers in cancers linked to Slug.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311016     DOI: 10.1016/j.ygeno.2005.09.014

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  19 in total

1.  Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma.

Authors:  Paras Jethwa; Mushal Naqvi; Robert G Hardy; Neil-A Hotchin; Sally Roberts; Robert Spychal; Chris Tselepis
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 2.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

3.  Slug regulates proliferation and invasiveness of esophageal adenocarcinoma cells in vitro and in vivo.

Authors:  Kejun Zhang; Shaoyan Zhang; Xuelong Jiao; Haibo Wang; Dianliang Zhang; Zhaojian Niu; Yi Shen; Liang Lv; Yanbing Zhou
Journal:  Med Oncol       Date:  2010-08-21       Impact factor: 3.064

4.  Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis.

Authors:  Qi Sun; Jacqueline Lesperance; Hiromi Wettersten; Elaine Luterstein; Yoko S DeRose; Alana Welm; David A Cheresh; Jay S Desgrosellier
Journal:  J Clin Invest       Date:  2017-12-11       Impact factor: 14.808

5.  Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.

Authors:  Michael A Augello; Craig J Burd; Ruth Birbe; Christopher McNair; Adam Ertel; Michael S Magee; Daniel E Frigo; Kari Wilder-Romans; Mark Shilkrut; Sumin Han; Danielle L Jernigan; Jeffry L Dean; Alessandro Fatatis; Donald P McDonnell; Tapio Visakorpi; Felix Y Feng; Karen E Knudsen
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

6.  p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug.

Authors:  Shu-Ping Wang; Wen-Lung Wang; Yih-Leong Chang; Chen-Tu Wu; Yu-Chih Chao; Shih-Han Kao; Ang Yuan; Chung-Wu Lin; Shuenn-Chen Yang; Wing-Kai Chan; Ker-Chau Li; Tse-Ming Hong; Pan-Chyr Yang
Journal:  Nat Cell Biol       Date:  2009-05-17       Impact factor: 28.824

7.  Potentiating effects of GHRH analogs on the response to chemotherapy.

Authors:  Andrew V Schally; Roberto Perez; Norman L Block; Ferenc G Rick
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

8.  Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models.

Authors:  Roberta Vitali; Camillo Mancini; Vincenzo Cesi; Barbara Tanno; Mariateresa Mancuso; Gianluca Bossi; Ying Zhang; Robert V Martinez; Bruno Calabretta; Carlo Dominici; Giuseppe Raschellà
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

9.  SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.

Authors:  Poornima Bhat-Nakshatri; Hitesh Appaiah; Christopher Ballas; Patricia Pick-Franke; Robert Goulet; Sunil Badve; Edward F Srour; Harikrishna Nakshatri
Journal:  BMC Cancer       Date:  2010-08-06       Impact factor: 4.430

10.  SFRP2 and slug contribute to cellular resistance to apoptosis in hypertrophic scars.

Authors:  Liang Chen; Zhenxiang Wang; Shirong Li; Guangjian Zhao; Maosheng Tian; Zhicheng Sun
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.